Back to Journals » Journal of Hepatocellular Carcinoma » Volume 1 » default
Journal of Hepatocellular Carcinoma
- View all (1026)
- Volume 13, 2026 (101)
- Volume 12, 2025 (220)
- Volume 11, 2024 (181)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Archive: Volume 1 , 2014
Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy
Bishay VL, Maglione K, Khanna R, Lee KM, Fischman AM, Lookstein RA, Kim E
Journal of Hepatocellular Carcinoma 2014, 1:187-193
Published Date: 27 November 2014
Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Aiolfi R, Sitia G
Journal of Hepatocellular Carcinoma 2014, 1:183-186
Published Date: 13 November 2014
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
Cappelli A, Pettinato C, Golfieri R
Journal of Hepatocellular Carcinoma 2014, 1:163-182
Published Date: 3 November 2014
Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
Braidwood L, Learmonth K, Graham A, Conner J
Journal of Hepatocellular Carcinoma 2014, 1:149-161
Published Date: 16 October 2014
Radiological diagnosis of hepatocellular carcinoma
Bargellini I, Battaglia V, Bozzi E, Lauretti DL, Lorenzoni G, Bartolozzi C
Journal of Hepatocellular Carcinoma 2014, 1:137-148
Published Date: 9 September 2014
Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
Hsu HT, Chi CW
Journal of Hepatocellular Carcinoma 2014, 1:127-135
Published Date: 26 August 2014
Hepatocellular carcinoma: epidemiology and risk factors
Kew MC
Journal of Hepatocellular Carcinoma 2014, 1:115-125
Published Date: 13 August 2014
Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
Torres HA, Kaseb A, Mahale P, Miller E, Frenette C
Journal of Hepatocellular Carcinoma 2014, 1:109-114
Published Date: 16 July 2014
Clinical utility of imaging for evaluation of hepatocellular carcinoma
Murakami T, Tsurusaki M, Hyodo T, Imai Y
Journal of Hepatocellular Carcinoma 2014, 1:101-108
Published Date: 14 July 2014
Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL
Journal of Hepatocellular Carcinoma 2014, 1:85-99
Published Date: 12 June 2014
New insights on the role of epigenetic alterations in hepatocellular carcinoma
Frau M, Feo CF, Feo F, Pascale RM
Journal of Hepatocellular Carcinoma 2014, 1:65-83
Published Date: 12 June 2014
Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA
Journal of Hepatocellular Carcinoma 2014, 1:55-63
Published Date: 9 June 2014
Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
Coleman SJ, Grose RP, Kocher HM
Journal of Hepatocellular Carcinoma 2014, 1:43-54
Published Date: 29 May 2014
Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
Ofuji K, Saito K, Yoshikawa T, Nakatsura T
Journal of Hepatocellular Carcinoma 2014, 1:35-42
Published Date: 21 May 2014
Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
Li L, Diao W, Zen K
Journal of Hepatocellular Carcinoma 2014, 1:21-33
Published Date: 21 May 2014
Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
Akiel M, Rajasekaran D, Gredler R, Siddiq A, Srivastava J, Robertson C, Jariwala NH, Fisher PB, Sarkar D
Journal of Hepatocellular Carcinoma 2014, 1:9-19
Published Date: 26 March 2014
A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors
Shi J, Keller JM, Zhang J, Keller ET
Journal of Hepatocellular Carcinoma 2014, 1:1-7
Published Date: 6 March 2014